Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Grace Therapeutics, Inc.

NASDAQ: GRCE · Life Sciences · 9 alerts · CIK 1444192

Share price
$1.75Close, Nov 16
Market cap
$36.8M
Shares outstanding
21.04MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Grace Therapeutics, Inc. filings on SEC EDGAR ↗

9:06 PM ET Form 4
Insider Buying

Grace Therapeutics Insider Opaleye Management Inc. Buys $18.5K of Stock

Opaleye Management Inc. bought 10,328 shares of Grace Therapeutics, Inc. at $1.79 a share, worth $18.5K in total on Nov 3, 2026. Shares held after the trade: 3,046,739 (+0.3%).

Value
$18.5K
Shares
10,328
Price
$1.79
Holding change
+0.3%
Trade date
Nov 3, 2026
6:06 PM ET Form 4
Insider Buying

Grace Therapeutics Insider Opaleye Management Inc. Buys $159K of Stock

Opaleye Management Inc. bought 87,801 shares of Grace Therapeutics, Inc. at $1.77 to $1.93 a share (average $1.81) in 2 transactions, worth $159K in total between Oct 22, 2026 and Oct 26, 2026. Shares held after the trade: 3,036,411 (+2.2%).

Value
$159K
Shares
87,801
Average price
$1.81
Holding change
+2.2%
Trade date
Oct 22, 2026 to Oct 26, 2026
8:43 PM ET Form 4
Insider Buying

Grace Therapeutics Insider Opaleye Management Inc. Buys $136K of Stock

Opaleye Management Inc. bought 71,065 shares of Grace Therapeutics, Inc. at $1.89 to $1.95 a share (average $1.92) in 3 transactions, worth $136K in total between Oct 14, 2026 and Oct 16, 2026. Shares held after the trade: 2,944,354 (+1.2%).

Value
$136K
Shares
71,065
Average price
$1.92
Holding change
+1.2%
Trade date
Oct 14, 2026 to Oct 16, 2026
5:45 PM ET Form 4
Insider Buying

Grace Therapeutics Insider Opaleye Management Inc. Buys $25.5K of Stock

Opaleye Management Inc. bought 12,555 shares of Grace Therapeutics, Inc. at $2.02 to $2.04 a share (average $2.03) in 2 transactions, worth $25.5K in total between Oct 9, 2026 and Oct 12, 2026. Shares held after the trade: 2,873,289 (+0.3%).

Value
$25.5K
Shares
12,555
Average price
$2.03
Holding change
+0.3%
Trade date
Oct 9, 2026 to Oct 12, 2026
6:46 PM ET Form 4
Insider Buying

Grace Therapeutics Insider Opaleye Management Inc. Buys $120K of Stock

Opaleye Management Inc. bought 58,796 shares of Grace Therapeutics, Inc. at $2.04 to $2.07 a share (average $2.05) in 2 transactions, worth $120K in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 2,856,963 (+0.7%).

Value
$120K
Shares
58,796
Average price
$2.05
Holding change
+0.7%
Trade date
Oct 1, 2026 to Oct 2, 2026
4:31 PM ET Form 4
Insider Buying

Grace Therapeutics Insider Opaleye Management Inc. Buys $16.4K of Stock

Opaleye Management Inc. bought 7,849 shares of Grace Therapeutics, Inc. at $2.09 a share, worth $16.4K in total on Sep 29, 2026. Shares held after the trade: 2,798,167 (+0.3%).

Value
$16.4K
Shares
7,849
Price
$2.09
Holding change
+0.3%
Trade date
Sep 29, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.